Osby E - Search Results

1

Parental longevity and prognosis in elderly patients with aggressive non-Hodgkin's lymphoma.

Osby E, Askling J, Landgren O, Dickman PW, Ekbom A, Björkholm M. Osby E, et al. Acta Oncol. 2004;43(3):297-301. doi: 10.1080/02841860410028510. Acta Oncol. 2004. PMID: 15244255 Clinical Trial.

2

Parental longevity and survival in elderly patients with Hodgkin's lymphoma.

Landgren O, Askling J, Dickman PW, Osby E, Axdorph U, Ekbom A, Björkholm M. Landgren O, et al. Among authors: osby e. Haematologica. 2002 Jun;87(6):596-601. Haematologica. 2002. PMID: 12031915

3

CHOP is superior to CNOP in elderly patients with aggressive lymphoma while outcome is unaffected by filgrastim treatment: results of a Nordic Lymphoma Group randomized trial.

Osby E, Hagberg H, Kvaløy S, Teerenhovi L, Anderson H, Cavallin-Stahl E, Holte H, Myhre J, Pertovaara H, Björkholm M; Nordic Lymphoma Group. Osby E, et al. Blood. 2003 May 15;101(10):3840-8. doi: 10.1182/blood-2002-10-3238. Epub 2003 Jan 16. Blood. 2003. PMID: 12531794 Free article. Clinical Trial.

4

CNOP (mitoxantrone) chemotherapy is inferior to CHOP (doxorubicin) in the treatment of patients with aggressive non-Hodgkin lymphoma (meta-analysis).

Björkholm M, Andersson T, Ahlbom A, Ösby E. Björkholm M, et al. Among authors: osby e. Eur J Haematol. 2008 Jun;80(6):477-82. doi: 10.1111/j.1600-0609.2008.01062.x. Epub 2008 Mar 10. Eur J Haematol. 2008. PMID: 18331601

5

Granulocyte function in elderly patients receiving chemotherapy for aggressive non-Hodgkin's lymphoma. Effect of granulocyte colony-stimulating factor.

Osby E, Björkholm M, Lundahl J, Forslid J. Osby E, et al. Eur J Intern Med. 2002 Oct;13(7):448. doi: 10.1016/s0953-6205(02)00137-1. Eur J Intern Med. 2002. PMID: 12384135

6

Mitoxantrone, etoposide, cytarabine and prednisone as salvage therapy for refractory non-Hodgkin lymphoma (NHL) and alternated with CHOP in previously untreated patients with NHL.

Merk K, Ideström K, Johansson B, Kimby E, Lindemalm C, Osby E, Björkholm M. Merk K, et al. Among authors: osby e. Eur J Haematol. 1991 Jan;46(1):33-7. doi: 10.1111/j.1600-0609.1991.tb00510.x. Eur J Haematol. 1991. PMID: 1988304

7

Addition of etoposide to CHOP chemotherapy in untreated patients with high-grade non-Hodgkin's lymphoma.

Celsing F, Widell S, Merk K, Bernell P, Grimfors G, Hedlund A, Liliemark J, Svedmyr E, Osby E, Björkholm M. Celsing F, et al. Among authors: osby e. Ann Oncol. 1998 Nov;9(11):1213-7. doi: 10.1023/a:1008446430765. Ann Oncol. 1998. PMID: 9862052 Clinical Trial.

8

Reproducibility of tumor response evaluation in patients with high-grade malignant non-Hodgkin's lymphoma.

Osby E, Taube A, Cavallin-Ståhl E, Hagberg H, Björkholm M. Osby E, et al. Med Oncol. 2001;18(2):137-40. doi: 10.1385/MO:18:2:137. Med Oncol. 2001. PMID: 11778759 Clinical Trial.

9

Oral etoposide in patients with hematological malignancies: a clinical and pharmacokinetic study.

Osby E, Liliemark E, Björkholm M, Liliemark J. Osby E, et al. Med Oncol. 2001;18(4):269-75. doi: 10.1385/MO:18:4:269. Med Oncol. 2001. PMID: 11918453 Clinical Trial.

10

Central nervous system occurrence in elderly patients with aggressive lymphoma and a long-term follow-up.

Björkholm M, Hagberg H, Holte H, Kvaloy S, Teerenhovi L, Anderson H, Cavallin-Ståhl E, Myhre J, Pertovaara H, Ost A, Nilsson B, Osby E. Björkholm M, et al. Among authors: osby e. Ann Oncol. 2007 Jun;18(6):1085-9. doi: 10.1093/annonc/mdm073. Epub 2007 Mar 15. Ann Oncol. 2007. PMID: 17363838 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Search Page

Filters